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Nuclear DBF-2-related (NDR) kinases are essential regula-
tors of cell cycle progression, growth, and development in
many organisms and are activated by the binding of an Mps
One Binder (MOB) protein partner, autophosphorylation,
and phosphorylation by an upstream STE20 family kinase. In
the protozoan parasite, Trypanosoma brucei, the causative
agent of human African trypanosomiasis, the NDR kinase,
PK50, is expressed in proliferative life cycle stages and was
shown to complement a yeast NDR kinase mutant cell line.
However, the function of PK50 and a second NDR kinase,
PK53, in T. brucei has not been determined to date, although
trypanosome MOB1 is known to be essential for cytokinesis,
suggesting the NDR kinases may also be involved in this proc-
ess. Here, we show that specific depletion of PK50 or PK53
from bloodstream stage trypanosomes resulted in the rapid
accumulation of cells with two nuclei and two kinetoplasts,
indicating that cytokinesis was specifically inhibited. This led
to a deregulation of the cell cycle and cell death and provides
genetic validation of these kinases as potential novel drug
targets for human African trypanosomiasis. Recombinant
active PK50 and PK53 were produced and biochemically
characterized. Both enzymes autophosphorylated, were able
to trans-phosphorylate generic kinase substrates in vitro, and
were active in the absence of phosphorylation by an upstream
kinase. Additionally, both enzymes were active in the absence
of MOB1 binding, which was also demonstrated to likely be a
feature of the kinases in vivo. Biochemical characterization of
recombinant PK50 and PK53 has revealed key kinetic differ-
ences between them, and the identification of in vitro peptide
substrates in this study paves the way for high throughput
inhibitor screening of these kinases.
Nuclear DBF2-related (NDR)3 kinases are important regula-
tors of a variety of cellular processes, including centrosome
duplication, mitotic exit, cytokinesis, morphogenesis, and
cell growth and development. The founding member of this
family, DBF2, is part of the mitotic exit network in Saccharo-
myces cerevisiae (1), although its counterpart in fission yeast,
Sid2, is a component of the septation initiation network (2).
Both kinases were recently shown to phosphorylate CDC14
phosphatase, promoting its retention in the cytoplasm and
allowing it to inactivate mitotic cyclin/cyclin-dependent kinase
and promote cell cycle progression (3, 4). OtherNDR kinases in
these yeasts (CBK1 in S. cerevisiae andOrb6 in Schizosaccharo-
myces pombe) regulate cellular morphogenesis (5, 6). In con-
trast, the fungal pathogen, Candida albicans, expresses only a
single DBF2 orthologue, which is essential for viability and
appears to have evolved multiple functions, being required for
mitotic spindle organization, actomyosin ring contraction, and
hyphal growth (7). In Drosophila, Tricornered/NDR1 (Trc/
NDR1) regulates dendritic tiling and branching (8) as well as
morphogenesis of epidermal outgrowths (9). A second NDR
kinase, Warts/Lats (Wts/Lts), in addition to a role in dendrite
maintenance (10), acts as a tumor suppressor, coordinating cell
proliferation and apoptosis (11), and phosphorylates the tran-
scriptional co-activator, Yorkie, which stimulates transcription
of cyclin E and the apoptosis inhibitor, Diap1. NDR phosphor-
ylation of Yorkie promotes its binding to 14-3-3 proteins in the
cytoplasm and hence inhibits its nuclear localization and func-
tion (12). Human cells express four NDR kinases, NDR1/2 and
LATS1/2. NDR1/2 regulate centrosome duplication (13), and
LATS1/2 phosphorylate the Yorkie homologue, Yes-associated
protein (YAP) (14), regulate organ size (15), and have tumor
suppressor functions, regulating progression through mitosis
(16).
NDR kinases are members of the AGC group of protein
kinases and are known to be activated by the binding of a Mps
One Binder (MOB) protein partner and also via phosphoryla-
tion of the kinase domain activation loop and a C-terminal
hydrophobic motif. In most AGC kinases, an upstream kinase
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phosphorylates both sites. However, NDR kinases autophos-
phorylate on the activation loop residue (Ser-281 in human
NDR1) (17). They also possess a basic insert sequence just
before the activation loop, which negatively regulates activity.
MOB protein binding at the N terminus of the kinase relieves
this inhibition, stimulates autophosphorylation, and activates
the kinase (18). It has also been suggested that in S. pombe,
MOB protein binding reduces an inhibitory self-association of
the Sid2 NDR kinase (2). STE20-like kinases further activate
NDR kinases by phosphorylating the hydrophobic motif (Thr-
444 in human NDR1) and also indirectly by phosphorylating
MOB, increasing its binding affinity for the NDR kinase (18–
20). Scaffolding proteins are also known to enhance the NDR/
MOB interaction (21, 22), and MOB binding has been shown
to target the NDR kinase to the plasma membrane, bringing
it into close proximity with its STE20 kinase activator (23,
24). Recently, phosphorylation of MOB1 by CDK1 in S. cer-
evisiae was reported to inhibit DBF2 kinase activity without
interfering with the MOB1/DBF2 interaction (25). Regula-
tion of NDR kinase activity is therefore complex and not yet
fully understood.
The protozoan parasite, Trypanosoma brucei, causes devas-
tating diseases of humans (human African trypanosomiasis)
and animals (Ngana) in sub-Saharan Africa. It has a digenetic
life cycle, split between mammalian and tsetse fly hosts. In the
mammalian bloodstream, the surface coat of the parasite
undergoes antigenic variation, and therefore a vaccine against
the parasite has so far proved elusive (26). Chemotherapies are
available to treat the disease but can cause undesirable and even
dangerous side effects, and only two drugs, melarsoprol and
difluoromethylornithine (DFMO or eflornithine), both paren-
terally administered, are effective against late stage disease,
characterized by the parasite crossing the blood-brain barrier
(27). The recently approved nifurtimox-eflornithine combina-
tion therapy (28) offers improved safety over DFMO mono-
therapy, but new drugs are still urgently needed.
The trypanosome cell cycle displays several unusual features
compared with mammalian cells, and it is likely that novel sig-
nal transduction pathways regulate these cellular processes.
Elucidation of these pathways could identify novel drug targets.
In particular, cytokinesis occurs via a distinctive physicalmech-
anism (29, 30). Whereas mammalian cells divide using a con-
tractile actomyosin ring, in the parasite, a furrow ingresses uni-
directionally from the anterior to the posterior along the helical
axis of the cell to divide the microtubule cytoskeleton and cell
contents. Parasite cell division is highly precise; a number of
single copy organelles must be replicated, segregated, and posi-
tioned accurately so that the furrow can pass between them to
generate two daughter cells with equivalent complements of
organelles. Any perturbation of cytokinesis results in disastrous
consequences for the parasite (30), suggesting that inhibiting a
parasite cytokinesis regulator might have therapeutic potential
for human African trypanosomiasis.
T. brucei expresses two MOB1 proteins (MOB1A and
MOB1B) and two putative NDR kinases, PK50 and PK53 (31,
32). The MOB1 proteins play essential roles during furrow
ingression in bloodstream stage trypanosomes, because their
depletion leads to an accumulation of post-mitotic cells with
partially ingressed furrows, resulting in deregulation of the cell
cycle (32). Previous data also suggested that MOB1A and PK50
can interact in procyclic (insect) form T. brucei (32). The func-
tions of the NDR kinases in trypanosomes have not been stud-
ied previously, although it was reported that PK50 is expressed
in dividing parasite life cycle stages and is able to complement
an Orb6 fission yeast mutant (31). We therefore sought to
determine whether the trypanosome NDR kinases were, like
theMOB1 proteins, also key cell cycle regulators, to investigate
the interactions between the NDR kinases and MOB1 proteins
and to evaluate the potential of the NDR kinases as novel drug
targets for human African trypanosomiasis.
EXPERIMENTAL PROCEDURES
Gene Sequences—In this study, gene fragments for cloning
were amplified from DNA from either EATRO795 or 427
strains. For PK53, DNA sequencing revealed only one nonsyno-
nymous mutation, resulting in a single predicted amino acid
change (E440D) compared with the 927 genome sequence
(GeneDB accession number Tb927.7.5770), present in both
EATRO795 (EMBL accession number FN550379) and 427
(FN550380) strains. For PK50, however, despite the corre-
sponding gene sequences from EATRO795 (FN550382) and
427 (FN550381) strains being almost identical, there were
more extensive changes compared with the 927 sequence
(Tb927.10.4940) and the AnTat1.1 sequence previously pub-
lished (supplemental Fig. S1) (31). The start codon of PK50 in
bloodstream T. brucei of strain 427 was confirmed by 5-rapid
amplification of cDNA ends to be equivalent to that previously
identified in AnTat1.1 (31), despite the presence of another
in-frame start codon upstream (supplemental Fig. S1A). Addi-
tionally, EATRO795, 427, and 927 PK50 sequences lack three
amino acids (Glu-111, His-112, and Arg-113) compared with
the AnTat1.1 sequence, and a temporary frameshift is also
present in AnTat1.1 compared with the other strains (sup-
plemental Fig. S1, B and C). Amino acids of PK50 referred to in
this study are numbered according to the 427 sequence (437
amino acids in length).
Culturing and Transfection of T. brucei—Bloodstream stage
T. brucei brucei were cultured and transfected as described
previously (33, 34). For RNA interference (RNAi) of PK50 or
PK53, the cell line 427 pLew13 pLew90 (35) was transfected
with pGL1709 or pGL1708, respectively, and dsRNA produc-
tion was induced by the addition of 1 g ml1 tetracycline to
the medium. pGL1709 was generated by cloning a 425-bp frag-
ment of the PK50 open reading frame amplified using the PCR
with oligonucleotides OL2518 and OL2519 (supplemental
Table S1), into p2T7ti:GFP (36), in place of the GFP-coding
sequence. pGL1708 was generated similarly, using a 427-bp
fragment of PK53 amplified with oligonucleotides OL2516 and
OL2517 (supplemental Table S1).
Real Time PCR Analysis—RNA preparation and cDNA syn-
thesis were carried out as described previously (33). Real time
PCR was performed using a Prism7500 real time PCRmachine
(Applied Biosystems). Oligonucleotides (PR23–PR26, supple-
mental Table S1) amplified an70-bp fragment of the gene of
interest distinct from the RNAi vector insert. Oligonucleotides
OL2272 and OL2273 (supplemental Table S1), recognizing a
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fragment of GPI8 (37), were used as an endogenous control.
PCRs were set up in triplicate, with each reaction containing
12.5l of SYBRGreenmaster mix (Applied Biosystems), 2.5l
each of oligonucleotide (3 M), 1 l of cDNA, and 6.5 l of
PCR-grade H2O. PCR conditions were as follows: 1 cycle of
50 °C for 2min, 1 cycle of 95 °C for 10min, followed by 40 cycles
of 95 °C for 15 s and 60 °C for 1 min. Resultant data were ana-
lyzed using Applied Biosystems 7500 system software.
Generation of Recombinant Proteins and Antisera—The
open reading frames encoding MOB1A, MOB1B, PK50, and
PK53 were PCR-amplified using the oligonucleotide pairs
detailed in supplemental Table S1, sequenced, and cloned into
pGEX-5X-1 (GE Healthcare), generating pGL1671 (GST:
MOB1A), pGL1672 (GST:MOB1B), pGL1674 (GST:PK50), and
pGL1673 (GST:PK53). Plasmids allowing the expression of
C-terminally His6-tagged NDR kinases were also constructed
by amplifying the PK50 and PK53 open reading frames (see
supplemental Table S1 for details of oligonucleotide pairs) and
cloning into pET21a (Novagen), generating pHG120 (PK50his)
and pHG119 (PK53his).
To allow the expression of NDR kinase dead variants, site-
directed mutagenesis of pGL1674, pGL1673, pHG120, and
pHG119 was performed using the Stratagene QuikChange XL
mutagenesis kit with oligonucleotides OL2531 and OL2532
(PK50) and OL2529 and OL2530 (PK53) (supplemental Table
S1) to mutate the invariant catalytic lysines to methionine
(K84M and K100M) (38), generating pGL1767, pGL1766,
pHG127, and pHG128, respectively. Sequencing confirmed
only the desired mutations had been introduced during the
PCR.
To express GST-tagged recombinant proteins, each plasmid
was transformed separately into Escherichia coli strain BL-21
(F, ompT,hsdSB(rBmB),dcm, gal) (GEHealthcare). Protein
expression was induced by the addition of 1 mM isopropyl -D-
thio-galactopyranoside to cultures growing at 30 °C, and
recombinant proteins were purified according to the Bulk and
RediPack GST purification module protocol (GE Healthcare).
For His-tagged protein purification, constructs were trans-
formed into Rosetta2(DE3) pLysS cells (Novagen) (F ompT
hsdSB(rBmB) gal dcm (DE3) pLysSRARE2 (CamR)), and pro-
tein expression was induced by the addition of 1 mM isopropyl
-D-thio-galactopyranoside to cultures growing at 37 °C. Fol-
lowing cell lysis by sonication, His-tagged proteins were puri-
fied on nickel-nitrilotriacetic acid-agarose.
Purified GST:PK50 and GST:PK53 were sent to the Scottish
Antibody Production Unit, Penicuik, Scotland, United King-
dom, for immunization of sheep to generate specific antisera
against PK50 and PK53, which were affinity-purified using pro-
tein A/G and GST columns sequentially and stored in phos-
phate-buffered saline. Western blotting showed the purified
anti-PK50 and anti-PK53 antiserum (used at 1:100 dilution) to
recognize proteins of the predicted sizes for PK50 (50.1 kDa)
and PK53 (53.0 kDa) in trypanosome cell lysates that were
depleted following PK50 or PK53 RNAi (Fig. 1C).
Anti-MOB1 antiserum (32) was used at a 1:100 dilution for
Western blotting. Anti-TY antibody (39), used at a 1:25 dilution
for Western blotting, was a gift from Keith Matthews, Univer-
sity of Edinburgh.
Immunofluorescence, 4,6-Diamidino-2-phenylindole (DAPI)
Staining, and Flow Cytometry—For immunofluorescence, 427
bloodstream stage cells (unsynchronized or synchronized with
hydroxyurea (40)) were fixed in 2.4% paraformaldehyde over-
night at 4 °C and processed according to Ref. 41. Anti-PK50 or
anti-PK53 antiserawere used undiluted as the primary antibod-
ies, while a 1:1000 dilution of AlexaFluor488-donkey anti-
sheep IgG (Molecular Probes) was used as secondary antibody.
DAPI staining of methanol-fixed T. brucei and flow cytometry
of propidium iodide-stained cells were carried out as described
previously (33).
Immunoprecipitation of NDRKinases andMOBProteins and
Kinase Assays—NDR kinases were immunoprecipitated from
427 wild type bloodstream cells or from the procyclic cell line
427 pHD449 (42) transfected with pGL1090 (MOB1Aty) or
pGL1165 (MOB1Bty). pGL1090 and pGL1165, based on a
pHD675 backbone (42), were generated by replacing the hygro-
mycin resistancemarkers of pGL850 andpGL1156 (32), respec-
tively, with a neomycin resistance marker. Induction of the
tagged MOB1 proteins was induced by the addition of 1 g
ml1 tetracycline for 16 h. 1 108 trypanosome cells were lysed
by snap-freezing in dry ice, resuspending in 1ml of ice-cold lysis
buffer (50mMMOPS, pH 7.4, 150mMNaCl, 1mMEDTA, 1mM
EGTA, 10 mMNaF, 1 mMNa3VO4, 1% Triton X-100, 10% glyc-
erol) with protease inhibitors (234 M leupeptin, 500 M phe-
nylmethanesulfonyl fluoride, 7.3 M pepstatin A, 2.5 M Pefa-
bloc, 250 M 1,10-phenanthroline, and 10 M E-64d), and
incubating on ice for 15 min. Cell debris was removed by cen-
trifuging at 100,000 g at 4 °C for 45 min. The clarified super-
natantwas incubatedwith the appropriate antibody for 2–3 h at
4 °C. Protein A/G beads (Pierce; 100 l bed volume) were then
added, and the resulting suspension was incubated with end
over end mixing for 2 h at 4 °C. The beads were washed four
times with lysis buffer, and immunoprecipitated proteins were
eluted by boiling in 2 NuPAGE loading buffer (Invitrogen).
Eluted proteinswere analyzed by SDS-PAGE followed byWest-
ern blotting. Immunoprecipitated proteins were also analyzed
for kinase activity bymixing 40l of beads (4 107 cell eq) with
20 l of kinase assay buffer (50 mM MOPS, pH 7.4, 20 mM
MgCl2, 2 mM dithiothreitol, 10 mM EGTA) supplemented with
5 g of myelin basic protein, 4 M ATP, and 0.037 MBq
[-32P]ATP (44). Reactions were incubated at 30 °C for 30 min
before being stopped by the addition of 20 l of 2 NuPAGE
loading buffer (Invitrogen) and heating to 70 °C for 10 min.
Reaction mixes were electrophoresed on NuPAGE gels
(Invitrogen); gels were stained with Coomassie Blue, dried, and
analyzed by phosphorimaging.
Kinase Assays Using Recombinant Proteins—Initial assays to
test the activity of recombinant protein preparations were per-
formed as described above by incubating 2 g of recombinant
protein(s) with 20 l of kinase assay buffer containing myelin
basic protein (MBP), histone H1, - or -casein substrates at
30 °C for 30 min.
Substrate Optimization—80 peptides (30M) and 3 proteins
(MBP, casein, and histone H1, 0.1 mg ml1) were tested in
duplicate as possible substrates of GST:PK50 or GST:PK53 (50
nM) in a filter plate assay (50 mMMOPS, pH 7.4, 20 mMMgCl2,
25 mM EGTA, 3 mM dithiothreitol, 30 M ATP, 7.4 kBq/well
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[-33P]ATP, at room temperature for 2 h). 5 nM Leishmania
mexicanaCRK3/LeishmaniamajorCYC6with histone H1 was
used as a positive control. Reactions were initiated by the addi-
tion of GST:PK50 or GST:PK53, incubated at room tempera-
ture, and stopped by the addition of 150 mM phosphoric acid.
Stopped reactions were then transferred to P-81 phosphocellu-
lose filter plates (Whatman), allowing the capture of peptide
substrate. Following three washes with 75 mM phosphoric acid
and onewashwithMeOH, plateswere dried at 40 °C for 20min,
and the retained signal was read on a TopCount NXT HTS
counter (PerkinElmer Life Sciences).
Biochemical Characterization of GST:PK50 and GST:PK53—
For more detailed characterization of the NDR kinases, opti-
mized kinase assay buffers (GST:PK50: 50 mM Tris-HCl, pH
7.9, 3 mM MnCl2, 0.1 mM EGTA, 3 mM dithiothreitol, 0.02%
CHAPS, 3 M Na3VO4, 0.2 mg/ml bovine serum albumin and
30 M ATP; GST:PK53: as for GST:PK50 but with 50 mM Tris-
HCl, pH 7.0, 0.02%CHAPS and 1mMMnCl2) with 8.9 kBq/well
[-33P]ATP and 30 M of the peptide substrate KKLRRTLSVA
(GST:PK50) or KKLNRTLSFAEPG (GST:PK53) were used.
Michaelis-Menten constants for the substrate peptide andATP
were determined in a time course-basedmatrix experiment using
the filterplate format.Under theconditions tested, all initial veloc-
ity reactions utilized less than 10% of the substrate load.
Staurosporine Inhibition Assays—Staurosporine potency
against GST:PK50 and GST:PK53 was tested across 10-point
serial dilutions of compound from 10 M to 5 nM (1% DMSO)
using the filter plate format. Potency was determined at the
respective Km values for ATP for each kinase with varying con-
centrations of peptide substrate.
Data Analysis—To determine bireactant kinetic parameters,
Equation 1 was used,
v  VmaxAB/KaKb KaB KbA AB
(Eq. 1)
where v represents the measured velocity; Vmax is the maxi-
mum velocity; [A] and [B] andKa andKb are the concentrations
and Michaelis-Menten constants, respectively, of substrates A
and B, and  is the cooperativity factor between the two sub-
strates (45). The parameter was fitted either as free or fixed to
1, and the best fit was assessed using the Akaike information
criterion (46). Graphs were plotted and analyses performed
using SigmaPlot 10.0. IC50 values were determined using the
following two parameter Equation 2 by nonlinear regression
using Prism 5,
Y  100/1  10∧logIC50 X  Hill slope (Eq. 2)
where the experimental data were corrected for background
and expressed as a percentage of inhibited enzyme activity.
In Equation 2, Y is the percentage of inhibition; X represents
the inhibitor concentration, and Hill slope is the slope factor.
Phosphosite Analysis—Phosphosite analysis was performed
by the FingerPrints Proteomics Facility, University of Dundee.
GST:PK50 and GST:PK53 were digested in-gel with trypsin
before being subjected to nano-liquid chromatography-tandem
mass spectrometry and precursor ion scanning (Parents of79
(PO3-)) using a 4000 QTRAP (Applied Biosystems).
FIGURE 1. PK50 and PK53 are essential for proliferation in bloodstream stage T. brucei. A, cumulative growth curves for two independent PK50 (left) and
PK53 (right) bloodstream stage RNAi clones in the presence and absence of tetracycline (tet). B, real time PCR, 10 h post-induction for PK50 (left) and PK53 (right)
RNAi cloneswithPK50- andPK53-specific oligonucleotides (oligos).RT, reverse transcriptase. Error bars show the standarderror over three replicates.C,Western
blotting, 15 h post-induction for PK50 (left) and PK53 (right) RNAi clones with anti-PK50 (top panel) and anti-PK53 (middle panel) antibodies. The lower panel
shows part of the polyvinylidene difluoride membrane following blotting, stained with Ponceau S, as a loading control. 106 cell eq were loaded per lane.
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RESULTS
PK50 and PK53 Are Essential Enzymes in Bloodstream Stage
T. brucei—To determine whether PK50 and PK53 are essential
for viability, and therefore have potential as new trypanosomi-
asis drug targets, their expression in bloodstream stage para-
sites was knocked down using an inducible RNAi system (35,
36). Stable PK50 and PK53 RNAi bloodstream cell lines were
generated, and two independent clonal cell lines for each kinase
were selected for analysis. Induction of the RNAi response for
either kinase resulted in a rapid growth defect observable from
12 h post-induction in both clones (Fig. 1A), leading to cell
death from 48 h post-induction, as evidenced by the decreasing
cell numbers. For PK50 RNAi cells, clone 1 died completely
following 96 h of RNAi induction, whereas the second clone
began to recover at this time, most
likely due to the presence of RNAi
revertants within the culture as has
been observed previously (47).PK53
RNAi cells died more slowly, with
only one of the two clones dying
completely by around 120 h post-in-
duction. However, for each kinase,
the growth defects observed were
accompanied by a reduction in spe-
cific mRNA levels (60–70% at 10 h
post-induction) as demonstrated by
real time PCR analysis (Fig. 1B).
Down-regulation of the kinase in
question was also confirmed at the
protein level by Western blotting
cell lysates, showing PK50 and
PK53 abundance decreased by
90% at 15 h post-induction (Fig.
1C). Down-regulation of either
NDR kinase did not significantly
affect themRNA or protein levels of
the other (Fig. 1, B and C), demon-
strating that each NDR kinase was
specifically targeted.
Trypanosome NDR Kinases Are
Required for Cytokinesis—To deter-
mine whether the growth defect
upon PK50 or PK53 depletion
occurred as a result of a cell cycle
defect, and whether these kinases
play roles in cytokinesis like MOB1,
cell cycle progression following
RNAi induction was analyzed by
fluorescence microscopy of DAPI-
stained cells to monitor the number
of nuclei and kinetoplasts per cell
and flow cytometry of propidium
iodide-stained cells tomonitor their
ploidy. DAPI staining is a useful tool
to monitor cell cycle progression
because trypanosomes contain a
single mitochondrion whose DNA
is organized into a disc termed the
kinetoplast; the kinetoplast replicates and divides ahead of the
nucleus allowing the classification of cell cycle stage for individ-
ual cells (48). The results for both clones for the PK50 and PK53
RNAi cell lines were very similar, and hence only data obtained
for clone 1 is presented here. Following depletion of either
kinase, DAPI staining revealed an initial increase in cells with
two nuclei and two kinetoplasts (2N2K cells), with a concomi-
tant decrease in 1N1K and 1N2K cells (Figs. 2A and 3A). Fol-
lowing PK50 RNAi, 2N2K cells, which constituted around 10%
of the population in uninduced cells, rose to over 25% of the
population at 9 h post-induction (Fig. 2A). Further examination
revealed that nearly 80% of these 2N2K cells had not yet com-
menced cytokinesis furrowing, around 15% were in the process
of furrowing, and only 5% were in the final stages of cytoki-
FIGURE 2. Characterization of bloodstream stage PK50 RNAi cell lines. A, nucleus and kinetoplast configu-
rations of cells over time following induction, as revealed by DAPI staining and fluorescence microscopy (n
	200 per time point). N, nucleus; K, kinetoplast. Other cell types predominantly include cells with 	2N and
	2K. B, characterization of cytokinesis stage of 2N2K cells from RNAi cell lines cultured in the presence or
absence of tetracycline (tet) at 9 h post-induction. C, example images of multinucleate and multikinetoplast
cells present in induced PK50 RNAi cell lines 15 h post-induction. Left panels, differential interference contrast
images; right panels, DAPI images. D, flow cytometry profiles of propidium iodide-stained cells over time after
PK50 RNAi induction. The x axis shows fluorescence intensity in the FL2-A channel. Time points and ploidy of
peaks are indicated.
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nesis (abscission) (Fig. 2B). In uninduced cultures, the distribu-
tion was notably different, with around 60% 2N2K cells yet to
commence furrowing,15%with a visible cleavage furrow, and
30% cells having reached abscission (Fig. 2B). This suggests that
onset of cytokinesis furrowing is delayed following depletion of
PK50. At later time points, cells with	2 nuclei and	2 kineto-
plasts were generated (Fig. 2, A, Other cell types, and C), but
very few zoids (0N1K cells) or 2N1K cells were formed. Flow
cytometry profiles of these cells showed that cells re-replicated
their nuclei and kinetoplasts, as demonstrated by the appear-
ance of 6C and 8C peaks following induction (Fig. 2D). These
data strongly suggest that PK50 is
essential for initiation of cytokine-
sis, and following its depletion, the
delay in entering cytokinesis allows
cells to re-replicate theirDNA, lead-
ing to cell cycle deregulation.
A slightly different phenotype
was observed following PK53 RNAi.
2N2Kcells doubled in abundance by
10 h post-RNAi induction (Fig. 3A),
and nearly 40% of these cells had a
visible cleavage furrow compared
with around 10% in uninduced con-
trol cells. There was no change in
the proportion of 2N2K cells yet to
commence furrowing, and very few
cells progressed to abscission,
strongly suggesting cytokinesis was
blocked at the level of furrow ingres-
sion. This represents a later cell
cycle block than that observed in
PK50RNAi cell lines and could indi-
cate the two kinases have different
functions in cell division. Neverthe-
less, as with PK50 RNAi, PK53
RNAi cells re-initiated multiple
rounds of organelle replication and
division at later time points as evi-
denced by DAPI staining (Fig. 3, A,
Other cell types, and C, images
showing cells with multiple, par-
tially ingressed cleavage furrows)
and flow cytometry (Figs. 3D, 6C
and 8C peaks). 2N1K and 0N1K
cells also appeared in similar pro-
portions after 20 h post-induc-
tion, suggesting that some 2N2K
cells may have been able to divide,
but at the expense of accuracy, thus
resulting in nonequivalent progeny.
A similar phenotype was observed
when MOB1 was depleted from the
insect procyclic form of T. brucei
(32).
Localization of NDR Kinases in T.
brucei—To investigate the localiza-
tion of the NDR kinases throughout
the cell cycle, immunofluorescence of PK50 and PK53 was
performed in bloodstream stage cells that had been synchro-
nized with hydroxyurea (40) to enrich for cells in particular
cell cycle stages (Fig. 4 and supplemental Fig. S2). Localiza-
tions were confirmed by examining unsynchronized cell
populations. Similar to a previous study where PK50 was
shown to localize to the cytoplasm in long slender blood-
stream and procyclic form parasites (31), immunofluores-
cence of bloodstream trypanosomes (using the anti-PK50
antibody generated in this study) gave a punctate cytoplas-
mic signal that disappeared in PK50 RNAi cell lines follow-
FIGURE 3. Characterization of bloodstream stage PK53 RNAi cell lines. A, nucleus and kinetoplast configu-
rations of cells over time following induction, as revealed by DAPI staining and fluorescence microscopy (n
	200 per time point). N, nucleus; K, kinetoplast. Other cell types predominantly include cells with 	2N and
	2K. B, characterization of cytokinesis stage of 2N2K cells from RNAi cell lines cultured in the presence or
absence of tetracycline (tet) at 10 h post-induction. C, example images of multinucleate and multikinetoplast
cells present in induced PK53 RNAi cell lines 15 h post-induction. Left panels, differential interference contrast
images; right panels, DAPI images. D, flow cytometry profiles of propidium iodide-stained cells over time after
PK53 RNAi induction. The x axis shows fluorescence intensity in the FL2-A channel. Time points and ploidy of
peaks are indicated.
NDR Kinases Are Essential for Trypanosome Cytokinesis
MAY 14, 2010•VOLUME 285•NUMBER 20 JOURNAL OF BIOLOGICAL CHEMISTRY 15361
ing tetracycline induction (supplemental Fig. S2). No obvi-
ous changes were noted in the distribution of the PK50 signal
throughout the cell cycle (supplemental Fig. S2A), including
during cytokinesis (supplemental Fig. S2B). PK53 also
appeared to be localized throughout the cytoplasm for most
of the cell cycle (Fig. 4A, 1N2K and 2N2K cells), and the
specificity of the antibody signal, as for PK50, was demon-
strated by performing immunofluorescence in cells induced
for PK53 RNAi. However, in many cells that were at an early
cell cycle stage, PK53 showed a more restricted localization,
confined predominantly to an area between the nucleus and
kinetoplast (Fig. 4A, 1N1K cell). Analysis of cells undergoing
cytokinesis revealed a widespread punctate localization of
PK53 during furrowing that became more restricted during
abscission as cells were about to re-enter into a new cell cycle
(Fig. 4B).
Purification and Activity of Recombinant NDR Kinases—To
confirm that PK50 and PK53 are bona fide protein kinases, they
were tagged at their N termini with aGST tag and purified from
E. coli. The recombinant kinases displayed activity in vitro
against the generic kinase substrate, MBP (Fig. 5), as well as
against histone H1 and - and -casein (data not shown).
This activity was abrogated when the invariant catalytic
lysine in the kinase domain of each kinase was mutated to
methionine (GST:PK50(K84M) and GST:PK53(K100M))
(Fig. 5, A and B, lane 5), indicating that contaminating co-
purified protein kinases were not responsible for the kinase
activity detected. Autophosphorylation of the NDR kinases
was also observed, in the presence or absence of substrate,
but not for the kinase-dead mutants. Neither of the kinases
was able to phosphorylate GST (data not shown), suggesting
that the autophosphorylation occurred on the NDR kinase
rather than the GST tag. This was confirmed by tryptic
digest and mass spectrometry analysis of GST:PK50 and
GST:PK53, which identified a number of phosphorylation
sites on the protein kinases (Tables 1 and 2). The PK50 activ-
ity data differ from a previous report, where an equivalent
GST:PK50 fusion protein autophosphorylated but did not
transphosphorylate MBP or histone substrates (31) and
could reflect the more optimal kinase assay buffer used here.
Given that previous data suggested PK50 could interact with
MOB1 in T. brucei (32), and in other eukaryotes, MOB1 is
required to activate its NDR kinase partner, the two trypano-
someMOB1 proteins,MOB1A andMOB1B, were also purified
as N-terminal GST fusion proteins and added to the kinase
assays. However, the activities of the NDR kinases were not
increased in the presence of either GST:MOB1 protein (Fig. 5,
lanes 3 and 4), and subsequent analyses showed that GST:
MOB1A/B did not bind to GST:PK50 or GST:PK53 (data not
shown). Attempts to alleviate possible steric hindrance of inter-
actions between these proteins due to the presence of the GST
tags by removal or replacement of the tags with smaller His6
tags were confounded by the poor solubility of the resulting
MOB1 proteins. NDR kinases tagged at the C terminus with a
His6 tag, like the GST-tagged kinases, underwent autophos-
phorylation and transphosphorylated MBP but were also not
bound or further activated by the GST:MOB1 proteins
(supplemental Fig. S3), indicating that the N-terminal GST tag
on the NDR kinase was not responsible for the lack of GST:
MOB1 binding.
Previously, using a procyclic EATRO795 cell line inducibly
expressing MOB1Aty, MOB1Aty was immunoprecipitated
with anti-TY antibody and a 50-kDa interacting protein de-
tected with a rabbit anti-PK50 antibody (31), suggesting that
PK50 andMOB1Aty formed a complex (32). In view of the data
FIGURE 4. Subcellular localization of PK53. A, immunofluorescence of 427
wild type bloodstream stage cells (top three cells) or PK53 RNAi cells (induced
for 24 h with 1 g ml1 tetracycline (tet), bottom cell) using anti-PK53 anti-
body. Differential interference contrast, DAPI, PK53, and DAPI/PK53 merged
(left to right) channels are shown for cells of different cell cycle stages. N,
nucleus; K, kinetoplast. B, PK53 immunofluorescence as in A for 2N2K cells
undergoing cytokinesis. Scale bars, 5 m.
FIGURE 5. Kinase assays with recombinant PK50 and PK53. A, left panel,
Coomassie Blue-stainedNuPAGE gel; right panel, phosphorimager scan. Lane
1, GST:PK50 only; lane 2, GST:PK50 plus MBP substrate; lane 3, GST:PK50 with
GST:MOB1A and MBP; lane 4, GST:PK50 with GST:MOB1B and MBP; lane 5,
GST:PK50(K84M) plus MBP substrate. The positions of the different proteins
are indicated. *, autophosphorylation of GST:PK50. B, as for A but with GST:
PK53 or GST:PK53(K100M) in place of GST:PK50 or GST:PK50(K84M),
respectively.
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above that indicate no such interaction between the NDR
kinases and MOB1 proteins in vitro, the interaction of these
proteins in vivo was analyzed in more detail. Because the anti-
PK50 antibody used in the original study no longer exists,
immunoprecipitations were performed with the sheep anti-
PK50 and anti-PK53 antibodies generated here, which were
demonstrated to be specific (Figs. 1C and 4A and sup-
plemental Fig S2A). Surprisingly, MOB1A/B were not co-im-
munoprecipitated from bloodstream cell lysates (strain 427)
with PK50 or PK53 (Fig. 6, A and B). Furthermore, the immu-
noprecipitated kinase fractions were active against MBP
despite the absence of MOB1 proteins (Fig. 6C). To determine
whether this represented a life cycle stage-specific difference in
MOB1:NDR kinase association, the immunoprecipitations
were also carried out using procyclic T. brucei 427 cell lysates
inducibly expressing MOB1Aty or MOB1Bty (supplemen-
tal Fig. S4). MOB1A/Bty did not co-purify with immunopre-
cipitated PK50 or PK53 (supplemental Fig. S4, A and B). Simi-
larly, the tagged MOB1 proteins immunoprecipitated from
these cell lines did not pull down either of the NDR kinases
(supplemental Fig. S4C). Additionally, MOB1Aty could not be
co-immunoprecipitated with PK50 using our sheep anti-PK50
antibody from the EATRO795-derived cell line used previously
(data not shown) (32).
Despite being unable to confirm the PK50:MOB1Aty inter-
action or to detect any interactions between PK50 andMOB1B
or between PK53 and MOB1A/B, we cannot completely rule
out that an interaction occurs between theMOB1 proteins and
PK50 and/or PK53 in vivo. Such an interaction may only occur
very transiently or under very specific conditions in the cell
cycle. For example, the phosphorylation status of the NDR
kinases or MOB1 proteins may be crucial to their interaction.
Nevertheless, the data generated here suggest that a significant
part of the NDR kinase pool does not interact with MOB1 pro-
teins and that MOB1 association with the NDR kinases is not
required for their activity in vivo.
Biochemical Characterization of NDR Kinases—To facilitate
subsequent biochemical analyses, NDR kinase assay conditions
were optimized. A collection of 80 synthetic peptides and
generic protein substrates (obtained from theDivision of Signal
Transduction Therapy, University of Dundee) was screened
with the GST:PK50 and GST:PK53 to identify optimal sub-
strates for each kinase. Two peptides, KKLNRTLSFAEPG and
KKLRRTLSVA, were found to be reproducibly phosphorylated
by GST:PK50 in vitro (Fig. 7A); KKLNRTLSFAEPG was also
found to be a good substrate for GST:PK53, along with
RARTLSFAEPG (Fig. 8A). Although these peptides have been
reported as relatively nonspecific kinase substrates (49), they do
contain an RXXS motif previously reported to be an NDR
kinase consensus sequence (3, 50). KKLRRTLSVA and KKLN-
RTLSFAEPG were used as the PK50 and PK53 substrates,
respectively, in all subsequent studies. Buffer optimization
matrix experiments were performed, varying pH andMgCl2/
MnCl2 concentration, and showed that for GST:PK50, a
buffer of pH 7.9 containing 3 mM MnCl2 increased the assay
signal 12-fold. For GST:PK53, the optimal buffer was of pH
7.0 with 1 mM MnCl2. All subsequent activity assays used
these optimized conditions, under which it was determined
TABLE 1
Identified phosphosites for GST:PK50
GST:PK50 was in-gel digested with trypsin, and resultant peptides were analyzed by nano-liquid chromatography-tandem mass spectrometry combined with parents of
79 (PO3 ) analysis. The phosphosites identified and their mass-to-charge ratios are shown in the table. Phosphorylated residues are highlighted in boldface. The
underlined serine or threonine residues indicate putative phosphosites where one of the underlined residues was phosphorylated, but the spectrum did not allow the
phosphorylated residue to be discriminated.
Residue Peptide Mascot (m/z) Pre79 (m/z)
Tyr-25 YTGEYYVK 551.7 (2
) 549.3 (2)
Ser-36 GMVGDKKSFAIEHSR 871.5 (2
) 869.5 (2)
Ser-216, Thr-217, or Ser-218 RDPDQAESTSVADDSYLTEDVTVDDDVK 1056.2 (2
) 1054.6 (2)
Ser-251 or Thr-252 KVMFFSTVGSPAYIAPEVLIGR 1231.8 (2
) 1229.7 (2)
Ser-251 or Thr-252 VMFFSTVGSPAYIAPEVLIGR 1167.7 (2
) 1165.7 (2)
Thr-394 and Ser-402 QPMTAVSREDQSVFVGFTSK 1187.6 (2
) 1185.7 (2)
Ser-402 EDQSVFVGFTSK 712.4 (2
) 711.4 (2)
Ser-402 and Thr-408 or Ser-409 EDQSVFVGFTSKLCDR 1024.5 (2
) 1022.6 (2)
Ser-434 FHELQNFSDDD 723.8 (2
) 721.4 (2)
TABLE 2
Identified phosphosites for GST:PK53
GST:PK53 was in-gel digested with trypsin, and resultant peptides were analyzed by nano-liquid chromatography-tandem mass spectrometry combined with parents of
79 (PO3-) analysis. The phosphosites identified and their mass-to-charge ratios are shown in the table. Phosphorylated residues are highlighted in boldface. The
underlined serine or threonine residues indicate putative phosphosites where one of the underlined residues was phosphorylated, but the spectrum did not allow the
phosphorylated residue to be discriminated.
Residue Peptide Mascot (m/z) Pre79 (m/z)
Ser-2 or Thr-3 GIPEFSTR (GIPEF is C-terminal end of GST sequence) 493.7 (2
)
Thr-17 or Ser-20 or Ser-23 GAAYTECSPISDVSHHK 970.4 (2
) 967.9 (2)
Ser-31 and Ser-33 ASASKAFLENHYR 827.3 (2
)
Ser-33 ASASKAFLENHYR 787.4 (2
) 785.3 (2)
Thr-48 GMLRDTR 464.7 (2
)
Ser-50 or Thr-53 SGNTARPVGPRPR 482.2 (2
)
Ser-114 or Ser-118 QISHVRSEK 582.3 (2
)
Ser-218 LTDFGLSKR 558.8 (2
)
Ser-298 IFESIVGSPGYIAPEILLR 1077.6 (2
) 1076.6 (2)
Ser-298 IFESIVGSPGYI 702.8 (2
) 701.4 (2)
Ser-298 RIFESIVGSPGYIAPEILLR 770.7 (3
) 1153.6 (2)
Tyr-458 GVIFADYKFNLK 747.8 (2
) 745.5 (2)
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that levels of NDR kinase autophosphorylation were negligi-
ble compared with exogenous substrate trans-phosphoryla-
tion (data not shown).
GST:PK50 and GST:PK53 were found to trans-phosphory-
late their peptide substrates linearly with respect to time and
enzyme concentration (Figs. 7, B and C, and 8, B and C). Fur-
thermore, by measuring initial reaction velocities in a matrix
experiment of varied ATP and peptide substrate concentra-
tions (Figs. 7D and 8D), the Km values of GST:PK50 and GST:
PK53 for ATP were determined to be 25.7 4.8 and 7.0 0.3
M, respectively, and for substrate 66.9 11.4 and 495.1 26.1
M, respectively, with no evidence of cooperativity. This was
further confirmed by the fact that the IC50 values for the generic
kinase inhibitor, staurosporine (216 47 nM forGST:PK50 and
4.6  0.3 nM for GST:PK53 (supplemental Fig. S5C)), did not
significantly shift under differing peptide concentrations (sup-
plemental Fig. S5, A and B).
DISCUSSION
This study demonstrates that the two trypanosome NDR
kinases are essential enzymes in bloodstream stage T. brucei,
thus providing genetic validation for these enzymes as putative
novel drug targets. Depletion of either kinase disrupted cytoki-
nesis, leading to cell cycle deregulation and cell death. The early
increase in 2N2K cells, observed at 5 h post-induction of PK50
or PK53 RNAi, argues that depletion of either of these kinases
has a specific effect on cytokinesis, because a growth arrest and
large numbers of abnormal cells in the population were only
observed after the appearance of increased numbers of 2N2K
cells. The phenotypes observed following depletion of the two
kinases were not identical, however. Following PK50 depletion,
most of the abnormal cells hadmultiple nuclei and kinetoplasts,
and, like the majority of the 2N2K cells, lacked cleavage fur-
rows. Very few zoids (0N1K cells), cells commonly formed
following aberrant cytokinesis, or 2N1K cells, which can form
following defects in basal body or kinetoplast replication or
segregation, or as a result of inaccurate furrowing, were present
following PK50 RNAi. Together, these data indicate that deple-
tion of PK50 prevents bloodstream stage cells from initiating
cytokinesis. In comparison, following PK53 depletion, partially
furrowed 2N2K cells accumulated. Additionally, at later time
points, 2N1K cells and zoids accumulated in equal numbers,
suggesting that some 2N2K cells didmanage to divide, but with
a loss of accuracy of furrow positioning. However, the accumu-
lation of cells with multiple nuclei and kinetoplasts partitioned
intomultiple cell bodies withmultiple partially ingressed cleav-
age furrows (Fig. 3C) indicates that completion of furrow
ingression was blocked in other dividing cells.
The different phenotypes observed for PK50 and PK53 could
indicate that these kinases act sequentially in a cytokinesis sig-
naling pathway, most likely with PK50 above PK53 in the cas-
cade. However, neither kinase was able to use the other as a
substrate in vitro (data not shown). Alternatively, because both
kinaseswere apparently depleted by similar proportions follow-
ing RNAi induction (Fig. 1C), the different phenotypes ob-
servedmay reflect different threshold levels for their function at
different stages of cytokinesis. Both kinases could conceivably
be required for the initiation and ingression of furrowing, but
the amount of residual PK53 protein was sufficient for initia-
tion of cytokinesis, whereas that of PK50 was not.
Immunofluorescence was performed for PK50 and PK53
across the cell cycle. However, despite the RNAi phenotypes
obtained, no specific localization to the cytokinesis furrow was
observed. One of the problems inherent in performing immu-
nofluorescence for any kinase is that, without a phosphospecific
antibody, it is not possible to distinguish the active protein
kinase pool from inactive forms. Hence, the total kinase pool
may mask a specific localization of the active pool. It is also
possible that these kinases do not localize to the cytokinesis
furrow themselves but instead phosphorylate a substrate,
which as a result then translocates to the furrow to bring about
cytokinesis. The more restricted localization of PK53 during
abscission and early stages in the cell cycle is intriguing but not
easy to explain without further study. However, this finding
FIGURE 6. Analysis of interactions between NDR kinases and MOB1
proteins in T. brucei 427 bloodstream stage cell lysates. A, PK50 was
immunoprecipitated with anti-PK50 antiserum, and immunoprecipitated
proteins were detected by Western blotting with anti-PK50 and anti-
MOB1 antibodies. As controls, immunoprecipitation (IP) was also per-
formed with an irrelevant antibody (anti-GFP), and cell lysates were also
incubated with beads without antibody (no Ab). I, sample input to beads;
FT, flow-through from beads; E, eluate. Ratio of loading (immunoprecipi-
tation/flow-through/eluate), 1:1:10. B, as for A, but showing immunopre-
cipitation of PK53 with anti-PK53 antiserum. C, kinase assays using eluates
from immunoprecipitations. Left panel, Coomassie Blue-stained NuPAGE
gel; right panel, phosphorimager scan. Lane 1, eluate from control immu-
noprecipitation (no antibody); lane 2, eluate from immunoprecipitation
with irrelevant antibody (anti-GFP); lane 3, eluate from anti-PK50 IP; lane 4,
eluate from anti-PK53 immunoprecipitation. The positions of the sub-
strate, MBP, and the 50-kDa marker are indicated. The50-kDa band vis-
ible on the autoradiograph may represent autophosphorylation of
PK53.
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may suggest additional roles for this kinase that have not been
revealed by our analysis to date of the RNAi cell lines.
PK50 and PK53 join a growing list of T. brucei signaling pro-
teins with direct roles in cytokinesis. A chromosomal passenger
complex has been reported to regulate the mitosis to cytokine-
sis transition (51–53) in bloodstream and procyclic trypano-
somes. TbRACK1 is required for furrow ingression in procyclic
T. brucei, although its depletion in bloodstream trypanosomes
appears to prevent cytokinesis initiation (54), and TbRACK1 is
thought to facilitate continued translation during cytokine-
sis (55). The Polo-like kinase, PLK1, is essential for furrow
ingression in the bloodstream form (56), as is the F-box pro-
tein, CFB2 (57), and MOB1 (32). MOB1 also plays roles in
accuracy of furrow ingression in procyclic trypanosomes.
RNAi of each of these regulators gives slightly different phe-
notypes, and given the incomplete nature and varied kinetics
of protein knockdown, as well as the relatively few protein/
protein interactions that have been determined between
these regulators, it is difficult to interpret the temporal order
of the signaling events that control trypanosome cytokinesis
at present.
This study provides the first biochemical analysis of the
trypanosome NDR kinases. Despite MOB1 proteins being
known activators of NDR kinases in a wide range of organisms,
the recombinant trypanosome NDR kinases were active in the
absence of MOB1 activation or phosphorylation by upstream
kinases. For PK50, this property was not unduly influenced by
the affinity tag, but for PK53, the C-terminal His6 tag led to
autophosphorylation being favored overMBP phosphorylation
(supplemental Fig. S3), although the reason for this is not clear
at present. In mammalian cells, protein phosphatase 2A has
been shown to remove the activatory phosphate groups (in the
activation loop and C-terminal hydrophobic motif) to inhibit
NDR1 (21, 58). It will be interesting to discover whether the
activities of the trypanosome kinases are regulated in a similar
manner in vivo.
Because of GST:MOB1A/B being unable to bind to recombi-
nant NDR kinases, we were unable to determine whether
MOB1 binding might have increased the activity of the kinases
still further. It is possible that the GST tag on the MOB1 pro-
teins prevented them from interactingwith theNDRkinases, or
that GST:MOB1 was not folded correctly, possibilities that we
FIGURE 7.Assaydevelopment forGST:PK50.A, substrate optimization. 80 peptides and 3proteins (concentration 30M and 0.1mgml1, respectively) were
tested in duplicate as possible substrates of GST:PK50 (50 nM) in a filter plate assay. Mean counts per min (cpm) obtained are shown. a and b, positive controls
(5 nM L. mexicana CRK3/L. major CYC6 against histone H1); c, KKLNRTLSFAEPG peptide, d, KKLRRTLSVA peptide. B, linearity of GST:PK50 assay over time at the
GST:PK50 concentrations indicated. Assays used 30 M KKLRRTLSVA peptide substrate and 30 M ATP. C, linearity of GST:PK50 assay with respect to enzyme
concentration.D,matrix experiment to allow the determination of the Km(app) for ATP and KKLRRTLSVA peptide. Reactions contained 15 nMGST:PK50, and the
concentrations of peptide and ATP are indicated. The initial reaction velocities (v) are shown.
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have not been able to rule out at present. However, we were
unable to co-immunoprecipitate the NDR kinases and
MOB1A/B proteins in vivo either, at least under the conditions
used in this study, suggesting the intriguing possibility that the
trypanosome NDR kinases are regulated by different mecha-
nisms in the trypanosome compared with other eukaryotes.
The reason for the discrepancy between the interaction data
generated here and previous data indicating an interaction
between PK50 and MOB1Aty in procyclic trypanosomes is
unclear and not possible to determine, given that supplies of the
original rabbit anti-PK50 antibody have been exhausted.
Although technical issues with the original experiment cannot
be ruled out, it is also possible that the rabbit anti-PK50 anti-
body (31) used previously recognized an 50-kDa protein in
trypanosome cell lysates that was not PK50, since a PK50 RNAi
cell line was not available at the time to confirm its in vivo
specificity. Because of the more comprehensive analysis of the
NDR kinase/MOB1 interactions, we believe that the data set
presented here is the more robust of the two analyses.
Given the data presented here, we favor a hypothesis
whereby theNDR kinases function largely independently of the
MOB1 proteins. However, we cannot completely rule out that
interactions between subpopulations of the MOB1 proteins
and NDR kinases do occur, perhaps very transiently. A specific
phosphorylation event or a scaffold protein could be required
for an NDR/MOB1 interaction to occur. Phosphorylation of
mammalian MOB1 at Thr-74 by the STE20 kinase, MST2, is
essential for its interaction with, and activation of, NDR1 (19),
and inDrosophila, phosphorylation of MOBKL1A/B at Thr-12
and Thr-35 by MST1/2 kinases increases their affinity for
LATS1 (20). Scaffolding proteins containing multiple HEAT/
Armadillo-like repeats can promote the activation of NDR
kinases in a variety of organisms (21). In Drosophila, Trc/NDR1
andMOB2were shown to interact with the Furry scaffolding pro-
tein, leading to activation of NDR1 (22, 59). In this system, the
MOB2/Furry interaction was dependent on phosphorylation of
MOB2. A recent phosphoproteomic study of bloodstreamT. bru-
cei (60) revealed that Ser-23 of MOB1A (Ser-40 in MOB1B) was
phosphorylated in vivo, but further investigation will be required
to determine the significance of this modification.
PK50 and PK53 have been shown to be phosphorylated in
vivo on Ser-434 and Ser-298, respectively (60). Ser-298 of PK53
FIGURE 8.Assaydevelopment forGST:PK53.A, substrate optimization. 80 peptides and 3proteins (concentration 30M and 0.1mgml1, respectively) were
tested in duplicate as possible substrates of GST:PK53 (50 nM) in a filter plate assay. Mean counts per min (cpm) obtained are shown. a and b, positive controls
(5 nM Leishmania mexicana CRK3/L. major CYC6 against histone H1); c, KKLNRTLSFAEPG peptide, d, RARTLSFAEPG peptide. B, linearity of GST:PK53 assay over
time at the GST:PK53 concentrations indicated. Assays used 30 M KKLNRTLSFAEPG peptide substrate and 30 M ATP. C, linearity of GST:PK53 assay with
respect to enzyme concentration.D,matrix experiment to allow the determination of the Km(app) for ATP and KKLNRTLSFAEPG peptide. Reactions contained 5
nM GST:PK53 and the concentrations of peptide and ATP indicated. The initial reaction velocities (v) are shown.
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is the activation loop serine, whereas Ser-434 of PK50 corre-
sponds to the most C-terminal serine residue and is not con-
served in other NDR kinases. Hence, this could indicate a
trypanosome-specific phosphoregulatory event. Phosphoryla-
tion of the activation loop serine (Ser-251) or the hydrophobic
motif threonine (Thr-408) of PK50 was not detected in the
study by Nett et al. (60. No other in vivo phosphosites were
detected for PK53, and theC-terminal hydrophobicmotif is not
conserved in this protein, again suggesting trypanosome-spe-
cific regulation of this kinase may occur. In this study, recom-
binant GST:PK50 was shown to be phosphorylated on Ser-434,
mimicking the in vivo situation, and Ser-251 and Thr-408 were
identified as putative phosphorylation sites. Additional phos-
phorylation sites were identified in the recombinant protein at
Tyr-25, Ser-36, Ser-216/Thr-217/Ser-218, Thr-394, and Ser-
402. GST:PK53 was found to be phosphorylated on Ser-298,
mimicking the in vivo data, and additional phosphorylation
sites were detected at Ser-2/Thr-3, Thr-17/Ser-20/Ser-23, Ser-
31, Ser-33, Thr-48, Ser-50/Thr-53, Ser-114/Ser-118, Ser-218,
andTyr-458. The in vivo significance of these phosphorylations
is not clear at present. However, although the presence of these
phosphosites suggests that PK50 and PK53 are able to auto-
phosphorylate on these residues in vitro, this does not rule out
that these modifications are performed by an upstream kinase
in vivo. NDR2 kinase is known to autophosphorylate its hydro-
phobicmotif threonine in vitro, although this event is primarily
performed by the STE20 kinase MST3 in vivo (17, 61). Addi-
tionally, although it is likely that some of these residues, e.g.
Ser-251 (activation loop) and Thr-408 (hydrophobic motif) in
PK50, are phosphorylated in vivo, similar to NDR kinases in
other organisms, it is not yet clear whether the other phos-
phosites identified represent bone fide in vivomodifications of
the NDR kinases.
NDR kinases are known to phosphorylate substrates with the
consensus sequence RXXS (3, 50), although relatively few in
vivo substrates have been identified for these kinases. Our sub-
strate screen showed our kinases to favor peptides with the
RXXS consensus sequence. Both kinases phosphorylated the
peptide KKLNRTLSFAEPG, but GST:PK50 was unable to
phosphorylate the GST:PK53 substrate RARTLSFAEPG,
whereas the GST:PK50-preferred substrate, KKLRRTLSVA,
was relatively poorly phosphorylated by GST:PK53. The in vivo
substrate specificities of these enzymes are still unknown, but it
is clear from the lethal RNAi phenotypes obtained upon deple-
tion of either kinase that they are not redundant enzymes in
bloodstream stage T. brucei. Biochemical characterization also
revealed differences between these kinases. Although GST:
PK50 and GST:PK53 were shown to have similar cation prefer-
ences (for both kinases, the in vitro activity dropped dramati-
cally in presence of Mg2
 and was restored by Mn2
), they
differ in their catalytic pocket as demonstrated by their differ-
ent affinities for ATP and the different potencies of staurospo-
rine. These findings are consistent with the presence of a 36-
amino acid insertion in the catalytic pocket of PK53 compared
with PK50.
PK50 and PK53 are about as similar to each other at the
amino acid level (30% identity and45% similarity, rising to
35% identity and50% similarity over the kinase domain) as
they are to human NDR/LATS kinases. It has been reported
that for kinases sharing 	60% identity over their catalytic
domain, there is a high likelihood that these enzymes will be
inhibited by the same group of low molecular weight com-
pounds (62) and suggested that there may therefore be a higher
probability of being able to identify selective small molecule
inhibitors for kinases sharing 60% identity (43). The differ-
ence in affinity of GST:PK50 and GST:PK53 for the generic
kinase inhibitor staurosporine provides preliminary evidence
that selective inhibition of these kinases is possible. Indeed,
using recombinant GST:PK50 andGST:PK53, high throughput
screening for small molecule inhibitors has now been per-
formed.4 Inhibitors based on distinct scaffolds with sub-micro-
molar IC50 values were identified for each recombinant kinase
that were selective against the majority of human kinases
tested. Work is ongoing to determine the trypanosome activity
and mode of action of these inhibitors.
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